{{Rsnum
|rsid=1143646
|Gene=HTT
|Chromosome=4
|position=3146926
|Orientation=plus
|GMAF=0.02296
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=HTT
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 1.8 | 7.1 | 91.2
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 1.0 | 5.9 | 93.1
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 3.5 | 96.5
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 7.8 | 92.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=19361997
|Title=Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients.
|OA=1
}}{{GET Evidence
|gene=HTT
|aa_change=Ile1091Met
|aa_change_short=I1091M
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1143646
|overall_frequency_n=352
|overall_frequency_d=9978
|overall_frequency=0.0352776
|n_genomes=1
|n_genomes_annotated=0
|n_haplomes=1
|n_articles=0
|n_articles_annotated=0
|gene_in_genetests=Y
|pph2_score=0.008
|genetests_testable=Y
|genetests_reviewed=Y
|nblosum100=-1
|autoscore=2
|webscore=N
}}